The effect of recombinant human erythropoietin on the treatment of anemia of prematurity

Rocha VL, Benjamin AC, Procianoy RS.

J Pediatr (Rio J). 2001 Mar-Apr;77(2):75-83. Portuguese.

PubMed: 14647595

https://www.ncbi.nlm.nih.gov/pubmed/14647595

Protocol

Anemia Treatment and Erythropoietin therapy Guidelines

Protocol based on scientific evidence for the non-transfusional treatment of anemia through the appropriate use of iron and erythropoietin.

Welcome to Bloodless

Background:

Blood transfusions are currently one of the most performed medical procedures in the world. However, the medical literature shows a relationship between the use of allogeneic (donated) blood and greater complications, including, greater mortality. Worldwide, there is a deficiency in medical knowledge about transfusion practice.

Objectives:

1. To change the current transfusion practice, through the application of scientifically safe and effective PROTOCOLS for the TREATMENT OF ANEMIA and MANAGEMENT OF BLEEDING without the use of allogeneic blood, based on the scientific evidence of modern medicine.

2. Help blood banks SAVE their main HEMOCOMPONENTS (red blood cells, plasma and platelets)